LOS ANGELES – Oct 26, 2023 – Stand Up To Cancer® (SU2C) has been recognized by two organizations for outstanding support of cutting-edge cancer research. Children’s Hospital of Philadelphia (CHOP) and the Society for Immunotherapy of Cancer (SITC) have both recognized the contributions and achievements SU2C has made in raising funds and awareness to help more people impacted by cancer thrive.
“We are thankful to CHOP and SITC for recognizing the role SU2C has played in advancing a collaborative and multi-disciplinary approach to cancer research and treatment, which was our goal when SU2C launched 15 years ago,” said Julian Adams, Ph.D., SU2C’s chief science officer. “Through innovative educational campaigns that reach a vast audience and raise awareness with the public and our unique funding models that provide the tools, resources and funding to help our investigators achieve patient benefits, we are aligned with CHOP and SITC in our goal to improve patient outcomes and create more long-term cancer survivors.”
CHOP has inducted SU2C into its President’s Circle, the hospital’s highest recognition that honors donors who have made investments in CHOP’s research exceeding $1 million.
Over the past decade, SU2C has awarded investigators at CHOP with more than $10.5 million in grants to fund eight teams of researchers or individual awards. SU2C-supported research at CHOP has spanned several cancer types that impact children and young adults – including acute lymphoblastic leukemia, hypermutant cancers and Ewing sarcoma – among other lines of inquiry that benefit children with other cancer types, all with the goal of helping pediatric cancer patients receive the best treatment possible.
SITC has bestowed SU2C’s co-founders with the 2023 Tara Withington Public Service Award in recognition of their leadership in bringing new, high-quality treatments to cancer patients as quickly as possible.
The award goes to all of SU2C’s co-founders, including Katie Couric, Sherry Lansing, Kathleen Lobb, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams, Ellen Ziffren as well as the late Laura Ziskin and Noreen Fraser. Thanks to the co-founders’ combined efforts, nearly $800 million has been pledged for SU2C’s innovative cancer research programs. The Tara Withington Public Service Award honors key contributors to the field of cancer immunotherapy and is named after SITC’s executive director of more than two decades.
# # #
Stand Up To Cancer
ABOUT STAND UP TO CANCER
Stand Up To Cancer® (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C is a 501(c)(3) charitable organization and was initially launched as a division of the Entertainment Industry Foundation. Established in 2008 by media and entertainment leaders, SU2C utilizes these communities’ resources to engage the public in supporting a new, collaborative model of cancer research, to increase awareness about cancer prevention, and to highlight progress being made in the fight against the disease. As of April 2023, more than 3,000 scientists representing more than 210 institutions are involved in SU2C-funded research projects.
As SU2C’s scientific partner, the American Association for Cancer Research (AACR) and a Scientific Advisory Committee, led by Nobel laureate Phillip A. Sharp, Ph.D., conduct rigorous competitive review processes to identify the best research proposals to recommend for funding, oversee grants administration, and provide expert review of research progress.
Current members of the SU2C Founders and Advisors Committee (FAC) include Katie Couric, Sherry Lansing, Kathleen Lobb, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams, and Ellen Ziffren. The late Laura Ziskin and the late Noreen Fraser are also co-founders. Russell Chew serves as SU2C’s president and CEO.